Triple

T18021313
Position Surface form Disambiguated ID Type / Status
Subject Parasympathetic nervous system E431121 entity
Predicate clinicalPharmacology P58407 FINISHED
Object target of muscarinic agonists and antagonists LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: target of muscarinic agonists and antagonists | Statement: [Parasympathetic nervous system, clinicalPharmacology, target of muscarinic agonists and antagonists]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: clinicalPharmacology
Context triple: [Parasympathetic nervous system, clinicalPharmacology, target of muscarinic agonists and antagonists]
  • A. medicalBackground
    Indicates that an entity has a history of prior medical conditions, treatments, or health-related experiences relevant to its current state or context.
  • B. hasPharmacologicalEffect chosen
    Indicates that one entity produces a specific pharmacological effect or action on another entity.
  • C. evaluatesDrug
    Indicates that an entity assesses or judges the properties, effectiveness, or impact of a drug.
  • D. evaluatedDrug
    Indicates that a particular drug has been assessed or tested, typically in the context of a study, experiment, or evaluation process.
  • E. clinicalEmphasis
    Indicates a focus or priority placed on clinical aspects, practices, or outcomes within a given context or activity.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8b904530081908bf341d842464856 completed April 10, 2026, 8:47 a.m.
NER Named-entity recognition batch_69e4b9c299c48190b0cceecf77cb6de9 completed April 19, 2026, 11:17 a.m.
PD Predicate disambiguation batch_69e3f904b8048190add43883cd7cb191 completed April 18, 2026, 9:35 p.m.
Created at: April 10, 2026, 10:24 a.m.